Characteristics of Clinical Trials Conducted in Japan Under the New GCP Guideline: Analysis of PMDA Audit Reports

Japanese Journal of Clinical Pharmacology and Therapeutics - Japan
doi 10.3999/jscpt.41.253
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Japanese Society of Clinical Pharmacology and Therapeutics